In Vitro Investigation of the Impact of Bacterial-Fungal Interaction on Carbapenem-Resistant


Journal

Molecules (Basel, Switzerland)
ISSN: 1420-3049
Titre abrégé: Molecules
Pays: Switzerland
ID NLM: 100964009

Informations de publication

Date de publication:
14 Apr 2022
Historique:
received: 28 02 2022
revised: 01 04 2022
accepted: 02 04 2022
entrez: 23 4 2022
pubmed: 24 4 2022
medline: 27 4 2022
Statut: epublish

Résumé

Fungal-bacterial co-culturing is a potential technique for the production of secondary metabolites with antibacterial activity. Twenty-nine fungal species were screened in a co-culture with carbapenem-resistant

Identifiants

pubmed: 35458737
pii: molecules27082541
doi: 10.3390/molecules27082541
pmc: PMC9026558
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Bacterial Proteins 0
Carbapenems 0
beta-Lactamases EC 3.5.2.6

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Références

J Infect Dis. 2014 Sep 1;210(5):803-13
pubmed: 24634498
Microbiology (Reading). 2008 Jan;154(Pt 1):167-175
pubmed: 18174135
Front Cell Infect Microbiol. 2018 Feb 23;8:21
pubmed: 29527517
APMIS. 2010 Jan;118(1):1-36
pubmed: 20041868
Microb Pathog. 2003 Nov;35(5):197-202
pubmed: 14521878
Front Microbiol. 2019 May 07;10:915
pubmed: 31134000
Sci Rep. 2019 Jan 18;9(1):218
pubmed: 30659217
J Infect Dis. 2000 Oct;182(4):1268-71
pubmed: 10979932
Eur J Biochem. 2001 Jul;268(13):3620-39
pubmed: 11432728
Front Public Health. 2016 Sep 30;4:209
pubmed: 27747206
Front Microbiol. 2017 Jul 11;8:1284
pubmed: 28744271
Curr Aging Sci. 2010 Dec;3(3):198-218
pubmed: 20735346
J Innate Immun. 2019;11(3):249-262
pubmed: 30605903
Annu Rev Biochem. 1981;50:715-31
pubmed: 6455965
Antimicrob Agents Chemother. 2003 Jul;47(7):2339-41
pubmed: 12821493
FEMS Microbiol Rev. 2012 Mar;36(2):340-63
pubmed: 21707670
Antimicrob Agents Chemother. 2014;58(1):467-71
pubmed: 24189247
Front Mol Biosci. 2019 Aug 14;6:71
pubmed: 31475158
J Nat Prod. 2011 Sep 23;74(9):1965-71
pubmed: 21879726
Antibiotics (Basel). 2020 Nov 28;9(12):
pubmed: 33260700
Eur J Clin Microbiol Infect Dis. 2020 May;39(5):987-992
pubmed: 31953591
Microbes Infect. 2011 Sep;13(10):808-17
pubmed: 21609780
Nat Rev Microbiol. 2005 Dec;3(12):937-47
pubmed: 16322742
Science. 2017 Apr 21;356(6335):311-315
pubmed: 28428424
Biotechnol Adv. 2014 Nov 1;32(6):1180-204
pubmed: 24651031
Curr Biol. 2014 Oct 20;24(20):2411-6
pubmed: 25308076
Bioinformatics. 2013 Aug 15;29(16):2041-3
pubmed: 23736529
FEMS Microbiol Ecol. 2005 Mar 1;52(1):49-58
pubmed: 16329892
Nat Rev Microbiol. 2015 Aug;13(8):497-508
pubmed: 26145732
BMC Public Health. 2012 Aug 02;12:594
pubmed: 22853006
Environ Microbiol Rep. 2015 Dec;7(6):990-1004
pubmed: 26472159
J Antimicrob Chemother. 2003 Mar;51(3):625-30
pubmed: 12615864
Nat Rev Drug Discov. 2015 Feb;14(2):111-29
pubmed: 25614221
Biomed Res Int. 2015;2015:871947
pubmed: 26064962
Antimicrob Agents Chemother. 2012 Jan;56(1):559-62
pubmed: 22083465
Infect Immun. 2007 Mar;75(3):1463-72
pubmed: 17220312
Science. 2019 May 24;364(6442):778-782
pubmed: 31123134
Ann Pharmacother. 2012 Jul-Aug;46(7-8):1086-96
pubmed: 22811350
Res Microbiol. 2018 Sep - Oct;169(7-8):372-383
pubmed: 29807096
Mayo Clin Proc. 2011 Nov;86(11):1113-23
pubmed: 22033257
Eur J Clin Microbiol Infect Dis. 2021 Jul;40(7):1451-1460
pubmed: 33559021
Curr Med Mycol. 2017 Jun;3(2):13-19
pubmed: 29354776
Sci Rep. 2019 Oct 28;9(1):15422
pubmed: 31659220
Surg Infect (Larchmt). 2018 Aug/Sep;19(6):629-633
pubmed: 29979638

Auteurs

Hani Moubasher (H)

Department of Botany and Microbiology, Faculty of Science, Cairo University, Giza 12613, Egypt.

Amani Elkholy (A)

Department of Clinical Pathology, Faculty of Medicine, Cairo University, Giza 12613, Egypt.

May Sherif (M)

Department of Clinical Pathology, Faculty of Medicine, Cairo University, Giza 12613, Egypt.

Mariam Zahran (M)

Department of Botany and Microbiology, Faculty of Science, Cairo University, Giza 12613, Egypt.

Sherif Elnagdy (S)

Department of Botany and Microbiology, Faculty of Science, Cairo University, Giza 12613, Egypt.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH